Does Rallies show 13F holders for AYTU?

Yes. Rallies tracks hedge fund and 13F ownership data for AYTU, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AYTU research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AYTU. It does not provide personalized investment advice.

AYTU (AYTU BioPharma, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

AYTU BioPharma, Inc. Common Stock (AYTU) is a publicly traded Healthcare sector company. As of May 21, 2026, AYTU trades at $2.20 with a market cap of $22.54M and a P/E ratio of -0.99. AYTU moved +0.00% today. Year to date, AYTU is -25.86%; over the trailing twelve months it is +5.91%. Its 52-week range spans $0.95 to $3.07. Analyst consensus is strong buy with an average price target of $9.33. Rallies surfaces AYTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AYTU stock?

Hedge funds tracked by Rallies that own AYTU include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AYTU BioPharma, Inc. Common Stock.

AYTU Key Metrics

Key financial metrics for AYTU
Metric	Value
Price	$2.20
Market Cap	$22.54M
P/E Ratio	-0.99
EPS	$-2.16
Dividend Yield	0.00%
52-Week High	$3.07
52-Week Low	$0.95
Volume	25
Avg Volume	0
Revenue (TTM)	$66.38M
Net Income	$-13.56M
Gross Margin	69.04%

Top Hedge Funds Holding AYTU

Renaissance Technologies holds 75.42K shares of AYTU, changed +0.94% as of Dec 31, 2024.
Citadel Advisors holds 11.06K shares of AYTU, changed -49.28% as of Dec 31, 2024.

Latest AYTU News

Aytu BioPharma Q3 Revenue Climbs 18% to $4.7M on Exua Prescription Surge — May 14, 2026

Recent AYTU Insider Trades

Disbrow Jarrett bought 16.67K (~$25.00K) on Jun 9, 2025.
Disbrow Joshua R. bought 66.67K (~$100.00K) on Jun 9, 2025.
Disbrow Joshua R. bought 15.00K (~$19.50K) on Feb 28, 2025.

AYTU Analyst Consensus

3 analysts cover AYTU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.33.

Common questions about AYTU

Who owns AYTU stock?: Hedge funds tracked by Rallies that own AYTU include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AYTU BioPharma, Inc. Common Stock.
Does Rallies show 13F holders for AYTU?: Yes. Rallies tracks hedge fund and 13F ownership data for AYTU, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AYTU research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AYTU. It does not provide personalized investment advice.